Atea Pharmaceuticals Inc. (AVIR)

Atea Pharmaceuticals Inc. (AVIR) – Analyst Ratings

Aug 10, 2023 04:48 AM JPMorgan Downgrades Atea Pharmaceuticals (AVIR) to Underweight, 'Limited COVID Market With Cases and Hospitalizations Shrinking'
Jan 7, 2022 09:45 AM Atea Pharmaceuticals' (AVIR) Continues to Have a Significant Market in COVID Response, Despite Data Setbacks - William Blair
Jan 6, 2022 06:50 AM
Nov 18, 2021 06:23 AM
Oct 20, 2021 03:50 AM
Oct 19, 2021 10:55 AM
Oct 5, 2021 04:58 AM
Sep 9, 2021 03:44 PM
Nov 25, 2020 08:08 AM
Nov 24, 2020 06:16 AM
Nov 24, 2020 06:10 AM
Nov 24, 2020 05:45 AM
Feb 15, 2017 07:17 AM
Feb 14, 2017 08:30 AM
Sep 21, 2016 07:16 AM
Jul 13, 2016 07:40 AM
May 27, 2016 12:20 PM